EPO is also widely used in interventional oncology, such as in transarterial chemoembolization (TACE) or as a radiopaque drug delivery vector [30,31], and can also be used as a fiducial marker for radiation therapy of hepatocellular carcinoma [32]. The gene discussed is EPO; the disease is hepatocellular carcinoma.